Free Trial

Raymond James Financial Inc. Makes New Investment in Azenta, Inc. (NASDAQ:AZTA)

Azenta logo with Medical background

Raymond James Financial Inc. acquired a new stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 46,612 shares of the company's stock, valued at approximately $2,331,000. Raymond James Financial Inc. owned about 0.10% of Azenta at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Ballentine Partners LLC grew its position in Azenta by 2.0% during the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company's stock worth $1,017,000 after acquiring an additional 404 shares during the last quarter. Picton Mahoney Asset Management grew its holdings in shares of Azenta by 305.7% in the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock worth $35,000 after purchasing an additional 532 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Azenta by 14.9% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,446 shares of the company's stock worth $225,000 after purchasing an additional 576 shares during the last quarter. KBC Group NV increased its stake in shares of Azenta by 48.5% in the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after buying an additional 698 shares during the period. Finally, Oregon Public Employees Retirement Fund raised its holdings in Azenta by 7.0% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 10,700 shares of the company's stock valued at $535,000 after buying an additional 702 shares during the last quarter. Hedge funds and other institutional investors own 99.08% of the company's stock.

Azenta Trading Down 0.4 %

NASDAQ AZTA traded down $0.12 during trading on Monday, hitting $26.85. The company had a trading volume of 60,276 shares, compared to its average volume of 652,350. The company's fifty day moving average is $33.14 and its 200-day moving average is $42.61. Azenta, Inc. has a one year low of $24.06 and a one year high of $63.58. The company has a market cap of $1.23 billion, a price-to-earnings ratio of -9.01 and a beta of 1.66.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. As a group, equities analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Evercore ISI raised their price target on shares of Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a report on Thursday, February 6th. TD Cowen upgraded Azenta to a "hold" rating in a report on Thursday, February 27th. Finally, Needham & Company LLC increased their price objective on Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a report on Thursday, February 6th.

Get Our Latest Stock Report on Azenta

About Azenta

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Further Reading

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines